Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.285 USD | +3.63% | -18.87% | +124.35% |
Apr. 22 | Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating | MT |
Apr. 22 | Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 319M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -72M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.39
x | P/E ratio 2025 * |
-4.68
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.51% |
Latest transcript on Ocugen, Inc.
1 day | +3.63% | ||
1 week | -18.87% | ||
Current month | -21.34% | ||
1 month | -29.51% | ||
3 months | +141.71% | ||
6 months | +222.50% | ||
Current year | +124.35% |
Managers | Title | Age | Since |
---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 12-12-31 |
Director of Finance/CFO | 42 | - | |
Jesse Simmers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 22-03-16 | |
Director/Board Member | 74 | 20-04-04 | |
Ramesh Kumar
BRD | Director/Board Member | 68 | 19-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1.285 | +3.63% | 3 811 982 |
24-04-22 | 1.24 | -6.06% | 7,685,032 |
24-04-19 | 1.32 | 0.00% | 6,646,607 |
24-04-18 | 1.32 | -8.33% | 8,069,804 |
24-04-17 | 1.44 | -9.43% | 7,220,787 |
Delayed Quote Nasdaq, April 23, 2024 at 11:28 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+124.35% | 319M | |
+2.21% | 42.11B | |
+49.22% | 40.08B | |
+8.33% | 40B | |
-10.82% | 26.87B | |
+7.74% | 24.58B | |
-22.67% | 18.44B | |
+2.20% | 11.94B | |
+31.64% | 11.66B | |
+7.98% | 11.01B |
- Stock Market
- Equities
- OCGN Stock